Capivasertib is a potential targeted therapy that provides a new treatment option for patients with specific types of breast CA. The drug has excellent therapeutic effects and is trusted by patients. This article will discuss in depth the therapeutic effects of Capivasertib and the key precautions when using the drug.
How effective is Capivasertib?
Since its approval by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), Capivasertib has been marketed in many countries and regions around the world for the treatment of specific types of breast diseases. Its therapeutic effect has attracted much attention and has become a hot topic among patients and the medical community.
The clinical treatment effect is relatively good
Capivasertib has shown excellent therapeutic effects in the treatment of patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast disease.
In particular, in FDA-approved trials, Capivasertib combined with fulvestrant can effectively delay disease progression and improve the quality of life of patients with PIK3CA/AKT1/PTEN changes.
The scope of application is gradually expanding
With the deepening of research, the scope of application of Capivasertib is also gradually expanding. On November 16, 2023, the US FDA once again approved Capivasertib for the treatment of a wider range of patients with HR-positive, HER2-negative locally advanced or metastatic breast diseases, which further confirmed its value in the treatment of breast diseases.
Capivasertib has shown excellent therapeutic effects in the treatment of specific types of breast diseases, bringing new treatment options and hope to patients. However, there are individual differences in the treatment effect. Patients should fully understand their own condition and drug properties before use, and work with doctors to develop personalized treatment plans.
Precautions for the use of Capivasertib
Although Capivasertib has achieved relatively outstanding results in the treatment of breast diseases, the precautions during its use are equally important. Understanding and following these precautions can ensure the safety and effectiveness of the medication and avoid potential risks.
Usage and dosage must be strictly followed
The recommended dosage and administration method of Capivasertib must be strictly followed by the doctor. The recommended dose of Capivasertib combined with fulvestrant is usually 400 mg, taken orally twice a day (about 12 hours apart) for 4 days, followed by a 3-day break. Patients should pay close attention to the time and dosage of medication during medication to avoid missing or overdosing.
Use with caution in special populations
Capivasertib should be used with caution in special populations such as pregnant women, lactating women, children, and men and women of reproductive potential. Pregnant women taking Capivasertib may cause harm to the fetus, so pregnant women and women of reproductive potential should consult a doctor before use to understand the potential risks of the drug and take effective contraceptive measures. In addition, the safety and effectiveness of Capivasertib for children have not been confirmed, so it is not recommended.
Monitor adverse reactions and deal with them in time
Capivasertib may cause a series of adverse reactions during treatment, including diarrhea, adverse skin reactions, and increased blood sugar. Patients should pay close attention to their physical condition during the use of the drug. If the above adverse reactions occur, they should inform the doctor in time and take appropriate treatment measures. The doctor will adjust the treatment plan according to the patient's specific situation to ensure the safety and effectiveness of the medication.
Capivasertib is an innovative therapeutic drug that brings new hope to patients with breast diseases, but the precautions during its use are equally important. Patients should fully understand the characteristics of the drug before use, follow the doctor's instructions, strictly control the usage and dosage, and pay close attention to their physical condition.
